NEW YORK (GenomeWeb) – Nanopore sequencing developer Quantapore said today it has raised nearly $15.6 million through the sale of Series 3 preferred stock.

Northern Light Venture Capital led the round. It was joined by Tsingyuan Ventures and Sangel Venture Capital as major investors and by Baidu Ventures and Cloudstone VC as additional investors. As part of the round, Northern Light Venture Capital founder Feng Deng has joined Quantapore's board of directors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
11
Sponsored by
PerkinElmer

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

Jan
31
Sponsored by
Roche

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.